The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

GW Pharmaceuticals PLC

Nasdaq: GWPH
Last

(U.S.) $126.06

Today's change+18.50 +17.20%
Updated September 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
 

GW Pharmaceuticals PLC

Nasdaq: GWPH
Last

(U.S.) $126.06

Today's change+18.50 +17.20%
Updated September 26 4:00 PM -4GMT. Delayed by at least 15 minutes.

GW Pharmaceuticals PLC Hits New 52-week High

GW Pharmaceuticals PLC closed up sharply Monday, rallying (U.S.)$18.50 or 17.20% to (U.S.)$126.06 and setting a new 52-week high. Over the last five days, shares have gained 19.59% and 81.54% year to date. Shares have outperformed the S&P 500 by 16.15% during the last year.

Key company metrics

  • Open(U.S.) $120.51
  • Previous close(U.S.) $107.56
  • High(U.S.) $126.47
  • Low(U.S.) $119.27
  • Bid / Ask(U.S.) $125.25 / (U.S.) $126.40
  • YTD % change+81.54%
  • Volume3,348,676
  • Average volume (10-day)849,258
  • Average volume (1-month)774,664
  • Average volume (3-month)604,431
  • 52-week range(U.S.) $35.83 to (U.S.) $126.47
  • Beta2.91
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEG0.71×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$3.50
Updated September 26 4:00 PM -4GMT. Delayed by at least 15 minutes.
S&P TSX0.53%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue2346
Total other revenue--------
Total revenue2346
Gross profit2235
Total cost of revenue1111
Total operating expense21252524
Selling / general / administrative6345
Research & development26262425
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-18-22-21-19
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-18-22-21-19
Income after tax-12-17-18-12
Income tax, total-6-5-3-6
Net income-12-17-18-12
Total adjustments to net income--------
Net income before extra. items-12-17-18-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-12-17-18-12
Inc. avail. to common incl. extra. items-12-17-18-12
Diluted net income-12-17-18-12
Dilution adjustment--------
Diluted weighted average shares263263261261
Diluted EPS excluding extraordinary itemsvalue per share-0.05-0.06-0.07-0.05
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.05-0.06-0.07-0.05